81 related articles for article (PubMed ID: 2528885)
1. The strong contractile effect of the thromboxane receptor agonist U-46619 in isolated human pulmonary arteries and its competitive antagonism by BM-13.505.
Sjöberg T; Steen S
Acta Physiol Scand; 1989 Jun; 136(2):161-5. PubMed ID: 2528885
[TBL] [Abstract][Full Text] [Related]
2. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848.
Arner M; Högestätt ED; Uski TK
Acta Physiol Scand; 1991 Jan; 141(1):79-86. PubMed ID: 2053448
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of thromboxane receptor induced contractions in isolated human groin lymphatics.
Sjöberg T; Andersson KE; Norgren L; Steen S
Lymphology; 1989 Sep; 22(3):135-40. PubMed ID: 2532276
[TBL] [Abstract][Full Text] [Related]
4. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.
Cocks TM; Kemp BK; Pruneau D; Angus JA
Br J Pharmacol; 1993 Sep; 110(1):360-8. PubMed ID: 8220898
[TBL] [Abstract][Full Text] [Related]
5. Further characterization of the contraction-mediating prostanoid receptors in feline cerebral arteries. Effects of the thromboxane-receptor antagonist AH 23848.
Uski TK
Acta Physiol Scand; 1988 Aug; 133(4):519-24. PubMed ID: 2976236
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of antagonism of thromboxane receptors in vascular smooth muscle.
Yanagisawa A; Smith JA; Brezinski ME; Lefer AM
Eur J Pharmacol; 1987 Jan; 133(1):89-96. PubMed ID: 3030773
[TBL] [Abstract][Full Text] [Related]
7. Effects of the thromboxane-receptor antagonist L-636,499 on feline cerebral arteries.
Uski TK; Andersson KE
Acta Physiol Scand; 1986 Dec; 128(4):605-11. PubMed ID: 2949488
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
Patscheke H; Stegmeier K; Müller-Beckmann B; Sponer G; Staiger C; Neugebauer G
Biomed Biochim Acta; 1984; 43(8-9):S312-8. PubMed ID: 6097235
[TBL] [Abstract][Full Text] [Related]
9. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a dilator function of 8-iso prostaglandin F2 alpha in rat pulmonary artery.
Jourdan KB; Evans TW; Curzen NP; Mitchell JA
Br J Pharmacol; 1997 Apr; 120(7):1280-5. PubMed ID: 9105703
[TBL] [Abstract][Full Text] [Related]
11. Regional differences in the prostanoid receptors mediating prostaglandin F2 alpha-induced contractions of cat isolated arteries.
Nakajima M; Ueda M
Eur J Pharmacol; 1990 Dec; 191(3):359-68. PubMed ID: 2086248
[TBL] [Abstract][Full Text] [Related]
12. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
Ogletree ML; Allen GT
J Pharmacol Exp Ther; 1992 Feb; 260(2):789-94. PubMed ID: 1531361
[TBL] [Abstract][Full Text] [Related]
13. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
Karasawa A; Shirakura S; Higo K; Kubo K
Arzneimittelforschung; 1991 Dec; 41(12):1237-41. PubMed ID: 1815522
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of a thromboxane A2-analogue U-46619 and noradrenaline on contractions of the human thoracic duct.
Sjöberg T; Steen S
Lymphology; 1991 Sep; 24(3):113-5. PubMed ID: 1753802
[TBL] [Abstract][Full Text] [Related]
15. Daltroban blocks thromboxane responses in the pulmonary vascular bed of the cat.
Hood JS; Nossaman BD; Ibrahim IN; McMahon TJ; Babycos CR; Kadowitz PJ
J Appl Physiol (1985); 1992 Jun; 72(6):2305-10. PubMed ID: 1385804
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of BAY u3405 on prostanoid-induced contractions in human isolated bronchial and pulmonary arterial muscle preparations.
Norel X; Labat C; Gardiner PJ; Brink C
Br J Pharmacol; 1991 Nov; 104(3):591-5. PubMed ID: 1797322
[TBL] [Abstract][Full Text] [Related]
17. Individual variations of prostanoid agonist responses in rabbit aorta: evidence for the independent regulation of prostanoid receptor subtypes.
Keith RA; Salama AI
Br J Pharmacol; 1987 Sep; 92(1):133-48. PubMed ID: 3664085
[TBL] [Abstract][Full Text] [Related]
18. Contractile properties of lymphatics from the human lower leg.
Sjöberg T; Steen S
Lymphology; 1991 Mar; 24(1):16-21. PubMed ID: 1646914
[TBL] [Abstract][Full Text] [Related]
19. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
20. BM 13.177 selectively inhibits endoperoxide analogue induced vascular contractions.
Janssens WJ; Deckmyn H; Gresele P; Vermylen J
Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):28-34. PubMed ID: 3840350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
